Delivery Order SPE2DB20D2104-SPE2DB22FS23X
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,136.08 firm fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. The contract has an ultimate completion date of October 30, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FN74S) valued at $5,539.01 for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract was awarded on March 7, 2022 by the Defense Logistics Agency (DLA), a component of the Department of Defense, with an ultimate completion date of March 8, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $1,718.90 for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 8, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $2,465.19 for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency, on May 24, 2022, with a performance completion date of May 25, 2022. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,196.95 for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 24, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,804.52 firm fixed-price delivery order is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. The award has an ultimate completion date of December 4, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $22,321.53 for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating it was competitively bid. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a $5,781.84 delivery order contract for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and does not have a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,641.41 firm fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of August 24, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $5,016.40, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The award has a performance period through February 12, 2024 and is a Firm Fixed Price Delivery Order contract. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FS23XDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides for the delivery of pharmaceutical products, including Trelegy Ellipta 100-62.5-25 60S, to the Defense Logistics Agency (DLA). The $2,955.47 Firm Fixed Price Delivery Order has a completion date of March 30, 2022 and was awarded on March 29, 2022. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that enables it to efficiently deliver a wide range of essential medications and medical supplies to support military healthcare programs globally. The contract does not have any set-aside designations, indicating open competition. In addition to the DLA IDC, Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 3/29/22 |